Why Cassava Sciences Stock Skyrocketed 145.1% in February

Why Cassava Sciences Stock Skyrocketed 145.1% in February
Keith Noonan, The Motley Fool
·2 min read

Promising results for the company's lead Alzheimer's drug have made Cassava one of 2021's most exciting stocks.